首页> 外文期刊>International Journal of Molecular Sciences >Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy
【24h】

Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy

机译:银纳米颗粒对乳腺炎感染山羊的金黄色葡萄球菌和铜绿假单胞菌的多重耐药菌株的影响:另一种抗菌治疗方法

获取原文
           

摘要

Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. Microorganisms generally acquire resistance to antibiotics through the course of antibacterial therapy. Multi-drug resistance (MDR) has become a growing problem in the treatment of infectious diseases, and the widespread use of broad-spectrum antibiotics has resulted in the development of antibiotic resistance by numerous human and animal bacterial pathogens. As a result, an increasing number of microorganisms are resistant to multiple antibiotics causing continuing economic losses in dairy farming. Therefore, there is an urgent need for the development of alternative, cost-effective, and efficient antimicrobial agents that overcome antimicrobial resistance. Here, AgNPs synthesized using the bio-molecule quercetin were characterized using various analytical techniques. The synthesized AgNPs were highly spherical in shape and had an average size of 11 nm. We evaluated the efficacy of synthesized AgNPs against two MDR pathogenic bacteria, namely, Pseudomonas aeruginosa and Staphylococcus aureus , which were isolated from milk samples produced by mastitis-infected goats. The minimum inhibitory concentrations (MICs) of AgNPs against P. aeruginosa and S. aureus were found to be 1 and 2 μg/mL, respectively. Our findings suggest that AgNPs exert antibacterial effects in a dose- and time-dependent manner. Results from the present study demonstrate that the antibacterial activity of AgNPs is due to the generation of reactive oxygen species (ROS), malondialdehyde (MDA), and leakage of proteins and sugars in bacterial cells. Results of the present study showed that AgNP-treated bacteria had significantly lower lactate dehydrogenase activity (LDH) and lower adenosine triphosphate (ATP) levels compared to the control. Furthermore, AgNP-treated bacteria showed downregulated expression of glutathione (GSH), upregulation of glutathione S-transferase (GST), and downregulation of both superoxide dismutase (SOD) and catalase (CAT). These physiological and biochemical measurements were consistently observed in AgNP-treated bacteria, thereby suggesting that AgNPs can induce bacterial cell death. Thus, the above results represent conclusive findings on the mechanism of action of AgNPs against different types of bacteria. This study also demonstrates the promising use of nanoparticles as antibacterial agents for use in the biotechnology and biomedical industry. Furthermore, this study is the first to propose the mode of action of AgNPs against MDR pathogens isolated from goats infected with subclinical mastitis.
机译:近年来,银纳米颗粒(AgNPs)已广泛用于各种应用中,如抗微生物剂,抗癌剂,诊断剂,生物标志物,细胞标记以及用于治疗各种疾病的药物递送系统。微生物通常通过抗菌疗法获得对抗生素的抗性。在治疗传染性疾病中,多药耐药性(MDR)已成为一个日益严重的问题,广谱抗生素的广泛使用已导致许多人类和动物细菌病原体对抗生素产生耐药性。结果,越来越多的微生物对多种抗生素具有抗性,从而在奶牛养殖中造成持续的经济损失。因此,迫切需要开发克服抗药性的替代的,成本有效的和有效的抗微生物剂。在此,使用各种分析技术对使用生物分子槲皮素合成的AgNP进行了表征。合成的AgNPs呈高度球形,平均大小为11 nm。我们评估了合成的AgNPs对两种MDR致病菌,即铜绿假单胞菌和金黄色葡萄球菌的功效,这些细菌是从感染乳腺炎的山羊乳样品中分离出来的。发现AgNPs对铜绿假单胞菌和金黄色葡萄球菌的最小抑制浓度(MIC)分别为1和2μg/ mL。我们的发现表明,AgNPs以剂量和时间依赖性方式发挥抗菌作用。本研究的结果表明,AgNPs的抗菌活性是由于活性氧(ROS),丙二醛(MDA)的产生以及细菌细胞中蛋白质和糖的泄漏所致。本研究的结果表明,与对照组相比,经AgNP处理的细菌的乳酸脱氢酶活性(LDH)明显降低,三磷酸腺苷(ATP)含量降低。此外,经AgNP处理的细菌显示出谷胱甘肽(GSH)的表达下调,谷胱甘肽S-转移酶(GST)的上调以及超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的下调。在AgNP处理过的细菌中始终观察到这些生理和生化指标,从而表明AgNPs可以诱导细菌细胞死亡。因此,以上结果代表了关于AgNP对不同类型细菌的作用机理的结论性发现。这项研究还证明了纳米颗粒作为抗菌剂在生物技术和生物医学行业中的应用前景广阔。此外,这项研究是第一个提出AgNPs对从感染亚临床乳腺炎的山羊分离的MDR病原体的作用方式的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号